Welcome to the Week in Review.

1. Big Pharma Caught In Contradiction

2. The Growing Impact Of The Inflation Reduction Act 

3. The Power of Public Pressure

PRICE WATCH: Lenmeldy, a new life-saving gene therapy for the genetic disorder metachromatic leukodystrophy (MLD) will be the most expensive drug in the world at $4.25 million. Innovation is worthless if patients can’t afford it — we urgently need to address the high launch prices of transformative cell and gene therapies coming to market.   

Have a great weekend!